BioSpace News Archive

BryoLogyx Inc., announced that David Crockford has joined the Company as vice president of clinical development and logistics, a new position.

Unique feature of bioSens-All™ technology enables discovery of therapeutics for pathologies linked to GPCR mistrafficking

Cellectricon, a collaborative services provider dedicated to advancing drug discovery and research in the areas of chronic pain and neurodegenerative diseases announces a collaboration with StressMarq Biosciences.

One entity will focus on pharmaceuticals and drug development, while the other will be aimed at consumer healthcare.

Martin Tolar, chief executive officer of Alzheon, told BioSpace that his company’s drug was designed to inhibit the formation of toxic soluble amyloid oligomers.

The first few minutes of your job interview are critical, as studies show hiring managers form strong impressions to make their hiring decisions based on these early minutes of the interview.

In response to the global health emergency caused by the recent outbreak of coronavirus strain 2019-nCoV, LGC’s SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostic manufacturers and clinical laboratories, is announcing the development of molecular reference materials for coronavirus utilizing their proprietary AccuPlex™ recombinant technology.

Collaborative Project with The Myositis Association To Be Featured at Summit

Be Cool Pharmaceutics LLC announced that they have obtained an exclusive license to a drug-composition patent which provides the capability of inducing a hibernation-like state.

It plans to launch a new, independent, publicly-traded company to handle those products. No name for the new company has been announced.